INTRODUCTION
Seborrheic dermatitis (SD), including its minor form, dandruff, is an important and common abnormal skin condition affecting about 5% to 10% of the population 1, 2 . It is characterized by flaking and scaling of the scalp, accompanied by itch and irritancy. The pathogenesis of SD is not completely understood yet, but a strong association with skin colonization by Malassezia yeasts has been suggested 3 .
Yeasts of the genus Malassezia are members of the human skin flora and are found in 75% to 98% of healthy adults 4 .
Most Malassezia yeasts are lipid-dependent, requiring an external source of lipids. For this reason, these cutaneous fungi prevail in body areas rich in sebaceous glands, such as the scalp, face, and upper trunk 5 . However, with some predisposing factors, these yeasts can be etiological agents of several skin disorders and uncommon systemic infections. They have been considered opportunistic pathogens of SD, and other conditions, including pityriasis versicolor, atopic dermatitis, folliculitis, and seborrheic blepharitis 6 .
With the development of molecular methods, such as polymerase chain reaction, Malassezia taxonomy has undergone a great transformation, with the expansion of the genus to the 14 species known today. Among the 14 species, Malassezia restricta and M. globosa are recognized as the most important pathogenic organisms in the development of dandruff and SD. However, an association of M. sympodialis, M. slooffiae, Malassezia obtusa, and M. furfur with SD has also been reported in some studies 4 .
Owing to its chronic course with remissions and relapses, SD management presents a challenge to clinicians. In vitro susceptibility tests Minimal inhibitory concentrations (MICs) were determined using the method suggested by Sugita et al. 10 with some modifications. Briefly, the extracts/reagents were diluted with 980 μl melted LN agar (LNA) medium to final concentrations ranging from 0.016 to 1 mg/ml. Malassezia species were grown in each well and incubated for three days at 34 o C to determine MICs.
We further compared the antifungal activity of the C. crenata shell and oil-soluble Glycyrrhiza extracts to that of ketoconazole. C. crenata shell extract, oil-soluble Glycyrrhiza extract, and ketoconazole were diluted with 980 μl melted LNA medium to final concentrations ranging from 15.63 to 1,000 μg/ml and 0.015 to 7.68 μg/ml, respectively. Malassezia strains were grown in each well of a 24-well plate and incubated for three days at 34 o C to determine MICs.
MIC values for C. neoformans and the Candida strains were determined in 96-well plates using a broth serial dilution method in accordance with the Clinical and Laboratory Standards Institute guideline. Fluconazole was used as a reference standard, and the final concentrations of the test reagents and fluconazole ranged from 0.1 to 1,000 μg/ml and 0.125 to 256 μg/ml, respectively.
RESULTS
The optimal growth of the Malassezia species was obtained in LN medium, and the results presented were obtained from four independent experiments. Overall, similar MIC values were obtained in each independently performed in vitro susceptibility test.
The MIC values of the eight candidate extracts and two natural products against M. restricta and M. globosa are presented in Table 1 . The Malassezia species showed susceptibility to five of the eight candidate extracts, i.e., the C. crenata shell, C. sinensis leaf, A. vulgaris, oil-soluble (Table 2 ).
In the experiments with the other yeast organisms, C. neoformans, C. albicans, C. tropicalis, and C. parapsilosis, the C. crenata shell and oil-soluble Glycyrrhiza extracts also demonstrated antifungal activity. The MIC values were considerably lower than those obtained against the Malassezia species and ranged from 3.9 to 15.6 μg/ml with the C. crenata shell extract and from 6.25 to 50 μg/ml with the oil-soluble Glycyrrhiza extract. Fluconazole also showed activity (MICs: 2∼8 μg/ml) against the Cryptococcus and three Candia strains (Table 3) .
DISCUSSION
Oral and topical antifungal agents became widely used for treatment of dandruff and scalp SD following the confirmation of the etiological relationship mentioned previously 11, 12 . In several previous studies, the severity of the disease was positively correlated with the number of microorganisms and lesions, which were generally confined to areas of heavy colonization. During treatment with topical antifungal agents, the yeast load was reduced, and clinical improvement was observed. Furthermore, when the disease recurred, the yeasts were presented in greater numbers 13, 14 .
In the present study, overall, three candidate extracts, including the C. crenata shell, C. sinensis leaf, and oil-soluble Glycyrrhiza extracts, generated relatively low MIC values against both M. restricta and M. globosa. This suggests that the extracts have anti-Malassezia activities against the major Malassezia species associated with SD and may potentially be active components in shampoos for SD. It is interesting that the three active extracts demonstrated much higher antifungal activities than phytosphingosine, which has been commonly used in various cosmetic products because of its anti-inflammatory and antimicrobial potency. It has previously been reported that the growth inhibition of M. furfur could be achieved in vitro at extremely high phytosphingosine concentrations (mean MIC of 6,250 μg/ml), whereas C. albicans strains were inhibited at concentrations between 152 and 269 μg/ml 15 .
However, the results showed some differences among the extracts in their effects on the Malassezia species. The greatest anti-Malassezia activities were detected in the C. crenata shell extract against M. restricta and in the oil-soluble Glycyrrhiza extract against M. globosa. The results also showed apparent differences between the two Malassezia species in their susceptibility to the A. vulgaris and A. membranaceus root extracts. This indicates that different Malassezia species can have different susceptibilities, which implies the importance of in vitro susceptibility tests. Interestingly, the C. crenata shell extract, which demonstrated prominent activity against M. restricta and M. globosa, showed no activity against M. sympodialis and M. slooffiae. This suggests that the therapeutic activity of the C. crenata shell extract against major pathogens of scalp SD could be selective. As previously reported by Kim et al. 16 , M. restricta and M. globosa are predominant Malassezia species associated with scalp SD in East Asia, with a frequency of 60% to 100% for each species. In contrast, M. sympodialis was found in 11.1% of East Asian scalp SD patients, and M. slooffiae was not detected in the above study. The oil-soluble Glycyrrhiza extract presented the same or higher activity than the C. crenata shell extract against M. restricta and M. globosa in the follow-up experiment. This suggests that the oil-soluble Glycyrrhiza extract is compatible with the C. crenata shell extract as an active reagent of anti-SD formulations. The C. crenata shell extract and oil-soluble Glycyrrhiza extract also showed fungistatic activity against the other common facultative pathogenic yeasts, Cryptococcus and Candida.
The results indicate the potential use of the extracts for other fungal infections. Both ketoconazole and fluconazole, commonly used antifungal agents, also showed positive inhibition, demonstrating that the assays were effective. Although various medicated and commercial shampoos with ketoconazole and zinc pyrithione have been on the market, patients have been repulsed by long-term exposure to these antifungal medications. As drug-resistant fungal infections have been on the rise over the past decade, plant sources increasingly attract more attention to provide new and more effective antifungal products [17] [18] [19] [20] .
Corticosteroids used to relieve scalp inflammation seem to be inappropriate for long-term and prophylactic use because of the chronic and relapsing nature of SD. Although steroids show efficacy and safety in short-term treatments, they could lead to frequent relapses shortly after the treatment discontinues 21, 22 . Shampoos containing plant extracts with anti-Malassezia activity would be an important part in a long-term treatment as an alternative and also for supportive management. In addition, it would be adequate to use them for prophylactic management in patients with mild dandruff or as a maintenance treatment to control SD. C. crenata is a species of chestnut. The inner shell of chestnut has been used topically as an anti-wrinkle and skin-firming agent for a long time in East Asia. It has also been reported that C. crenata shell extract has anti-inflammatory/anti-allergic activity, which inhibits mast cell degranulation 24 . However, no information on its antifungal activity has been previously published to our knowledge.
The oil-soluble Glycyrrhiza (licorice) extract is a well-known herbal ingredient in various cosmetics for its skin whitening effects. Some reports have described the in vitro antimicrobial and antifungal activity of the oil-soluble Glycyrrhiza extract. Rohinishree and Negi 25 reported inhibitory efficacy of licorice extract in controlling growth and pathogenicity of Staphylococcus aureus. Sato et al. 26 described antifungal activity of the oil-soluble Glycyrrhiza extract against Arthrinium sacchari and Chaetomium funicola and raised the possibility of adding the preparation made from the extract to beverages in polyethylene terephthalate bottles. However, as the dermatologic field lacks scientific evidence for fungistatic activity of the oil-soluble Glycyrrhiza extract, little is known on its potential use for the treatment of skin disease. Especially, no research has been reported on its activity against Malassezia species associated with SD to our knowledge. In conclusion, commercial or medicated shampoos containing C. crenata shell and oil-soluble Glycyrrhiza extracts could be a long-term treatment of choice for SD, although more advanced studies are required. The anti-inflammatory/-allergic activity of the extracts might also help to control symptoms of scalp SD. This study provides the foundation for further research to develop new anti-Malassezia shampoos with C. crenata shell and oil-soluble Glycyrrhiza extracts.
